Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Prospective, Post Market Observational Registry Study to Observe the Performance and Safety of the StypCel™ Device to Achieve Hemostasis During Neurosurgery

NCT07199439 is registered in ClinicalTrials.gov with Medprin Regenerative Medical Technologies Co., Ltd. as lead sponsor.

NCT NCT07199439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07199439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Prospective, Post Market Observational Registry Study to Observe the Performance and Safety of the StypCel™ Device to Achieve Hemostasis During Neurosurgery
Lead sponsor
Medprin Regenerative Medical Technologies Co., Ltd.
Phase
Observational
Overall status
Completed
Start date
April 23, 2023
Completion date
October 15, 2024
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurosurgery